nrc.ca (E. Vinogradov)
National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, USA
Plesiomonas shigelloides O17 LPS contains the same O-antigenic polysaccharide chain as a causative agent of dysentery, Shigella sonnei. This polysaccharide can be used as a component of a vaccine against dysentery. Core part of the P. shigelloides O17 LPS was studied using NMR and mass spectrometry and the following structure was proposed: Significant similarity of the P. shigelloides O17 LPS core with the structure of the P. shigelloides O54 core was observed
13C NMR, 1H NMR, methylation, GLC-MS, sugar analysis, GLC, mild acid hydrolysis, alkaline degradation, NMR-1D
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6 C7
5,3,2 50%bDGlcp 104.1 74.6 76.0 70.4 76.5 61.9
5,3,3,4,6,4,3,2 Ac
5,3,3,4,6,4,3 aLAltpNA 102.2 52.7 69.4 70.5 79.2 176.2
5,3,3,4,6,4,2 Ac
5,3,3,4,6,4 bDFucpN4N 102.4 52.1 77.1 55.9 68.6 16.7
5,3,3,4,6,2 Ac
5,3,3,4,6 bDGlcpN 102.6 56.4 73.7 79.6 75.9 61.2
5,3,3,4 aDGlcpN 97.6 55.3 70.8 70.5 72.4 68.9
5,3,3 aDGalpA 102.6 69.9 68.9 81.0 72.9 176.5
5,3,7,7,4 aDGalpN 96.1 52.3 67.6 69.3 72.4 62.0
5,3,7,7 aDGalpA 100.0 69.3 70.3 78.3 71.3 177.2
5,3,7 aXLDmanHepp 103.2 71.5 71.8 67.2 73.7 68.8 72.2
5,3 aXLDmanHepp
5,4 bDGalp 104.8 72.2 73.8 69.8 76.4 62.9
5 aXLDmanHepp
?XKdo?
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6 H7
5,3,2 50%bDGlcp 4.61 3.24 3.53 3.47 3.63 3.81-3.91
5,3,3,4,6,4,3,2 Ac
5,3,3,4,6,4,3 aLAltpNA 4.90 3.99 3.67 4.39 4.41 -
5,3,3,4,6,4,2 Ac
5,3,3,4,6,4 bDFucpN4N 4.58 3.85 4.18 4.00 4.11 1.34
5,3,3,4,6,2 Ac
5,3,3,4,6 bDGlcpN 4.51 3.77 3.69 3.67 3.51 3.65-3.84
5,3,3,4 aDGlcpN 5.17 3.27 3.87 3.50 4.32 3.83-4.08
5,3,3 aDGalpA 5.46 3.86 4.22 4.43 4.59 -
5,3,7,7,4 aDGalpN 5.28 3.47 4.13 4.04 4.34 3.75-3.75
5,3,7,7 aDGalpA 5.03 3.95 4.08 4.52 4.32 -
5,3,7 aXLDmanHepp 4.92 3.96 3.86 3.90 3.63 4.24 3.64-3.83
5,3 aXLDmanHepp
5,4 bDGalp 4.42 3.58 3.66 3.89 3.68 3.68-3.71
5 aXLDmanHepp
?XKdo?
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6 C7/H7
5,3,2 50%bDGlcp 104.1/4.61 74.6/3.24 76.0/3.53 70.4/3.47 76.5/3.63 61.9/3.81-3.91
5,3,3,4,6,4,3,2 Ac
5,3,3,4,6,4,3 aLAltpNA 102.2/4.90 52.7/3.99 69.4/3.67 70.5/4.39 79.2/4.41
5,3,3,4,6,4,2 Ac
5,3,3,4,6,4 bDFucpN4N 102.4/4.58 52.1/3.85 77.1/4.18 55.9/4.00 68.6/4.11 16.7/1.34
5,3,3,4,6,2 Ac
5,3,3,4,6 bDGlcpN 102.6/4.51 56.4/3.77 73.7/3.69 79.6/3.67 75.9/3.51 61.2/3.65-3.84
5,3,3,4 aDGlcpN 97.6/5.17 55.3/3.27 70.8/3.87 70.5/3.50 72.4/4.32 68.9/3.83-4.08
5,3,3 aDGalpA 102.6/5.46 69.9/3.86 68.9/4.22 81.0/4.43 72.9/4.59
5,3,7,7,4 aDGalpN 96.1/5.28 52.3/3.47 67.6/4.13 69.3/4.04 72.4/4.34 62.0/3.75-3.75
5,3,7,7 aDGalpA 100.0/5.03 69.3/3.95 70.3/4.08 78.3/4.52 71.3/4.32
5,3,7 aXLDmanHepp 103.2/4.92 71.5/3.96 71.8/3.86 67.2/3.90 73.7/3.63 68.8/4.24 72.2/3.64-3.83
5,3 aXLDmanHepp
5,4 bDGalp 104.8/4.42 72.2/3.58 73.8/3.66 69.8/3.89 76.4/3.68 62.9/3.68-3.71
5 aXLDmanHepp
?XKdo?